Market Tracker

09/30 5:16pm ET

Trovagene Inc (NASDAQ:TROV)

4.49
Delayed Data
As of Sep 30
 +0.21 / +4.91%
Today’s Change
2.85
Today|||52-Week Range
7.18
-16.85%
Year-to-Date
No recent news for Trovagene Inc.

Today’s Trading

Previous close4.28
Today’s open4.33
Day’s range4.28 - 4.52
Volume199,276
Average volume (3 months)302,631
Market cap$135.4M
Dividend yield--
Data as of 3:59pm ET, 09/30/2016

Growth & Valuation

Earnings growth (last year)-37.50%
Earnings growth (this year)-27.62%
Earnings growth (next 5 years)--
Revenue growth (last year)+11.65%
P/E ratioNM
Price/Sales456.64
Price/Book2.74

Competitors

 Today’s
change
Today’s
% change
PMDPsychemedics Corp-0.04-0.20%
CPHRCipher Pharmaceutica...-0.18-4.65%
CCMConcord Medical Serv...+0.09+2.31%
CDNACareDx Inc-0.21-5.59%
Data as of 4:04pm ET, 09/30/2016

Financials

Next reporting dateNovember 3, 2016
EPS forecast (this quarter)-$0.33
Annual revenue (last year)$312.8K
Annual profit (last year)-$27.5M
Net profit margin-8,781.98%

Profile

Sector
Health Technology
Industry
Biotechnology
Chief Executive Officer &
Director
William J. Welch
Chief Scientific Officer
Mark Erlander
Corporate headquarters
San Diego, California

Forecasts